<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Jain | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/cupneon57/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/cupneon57/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Jain.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">f9d00c003a8309b11aa44150a45964ab</guid>
				<title>Jain posted an update: Trial participants tended to possess lower clinical stages. [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41329/</link>
				<pubDate>Sat, 08 Feb 2025 08:07:17 -0800</pubDate>

									<content:encoded><![CDATA[<p>Trial participants tended to possess lower clinical stages. Multivariable analyses revealed registry patients with significantly worse survival compared with trial participants. The hazard ratio of LAP to OP among registry patients was 0.305 (95% CI; 0.048-2.188), which did not meet the prespecified generalizability criteria of 0.9. CONCLUSIONS&hellip;<span class="activity-read-more" id="activity-read-more-41329"><a href="http://www.nationalboardinstitute.com/activity/p/41329/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2f7f50650f915b13f9466e92601bec47</guid>
				<title>Jain posted an update: Furthermore, IsdB-expressing bacterial cells bound [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37867/</link>
				<pubDate>Tue, 04 Feb 2025 08:08:57 -0800</pubDate>

									<content:encoded><![CDATA[<p>Furthermore, IsdB-expressing bacterial cells bound significantly higher amounts of Vn from human plasma than did an isdB mutant. Adherence to and invasion of epithelial and endothelial cells by IsdB-expressing S. aureus cells was promoted by Vn, and an αvβ3 integrin-blocking monoclonal antibody or cilengitide inhibited adherence and invasion by s&hellip;<span class="activity-read-more" id="activity-read-more-37867"><a href="http://www.nationalboardinstitute.com/activity/p/37867/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3c5315bcda83fedde8faa7a0a287ec3f</guid>
				<title>Jain posted an update: Multiple sclerosis (MS) is a serious central nervous system [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35136/</link>
				<pubDate>Sat, 01 Feb 2025 08:08:36 -0800</pubDate>

									<content:encoded><![CDATA[<p>Multiple sclerosis (MS) is a serious central nervous system (CNS) disease responsible for disability problems and deterioration of the quality of life. Several approaches have been applied to medications entering the market to treat this disease. However, no effective therapy currently exists, and the available drugs simply ameliorate the&hellip;<span class="activity-read-more" id="activity-read-more-35136"><a href="http://www.nationalboardinstitute.com/activity/p/35136/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f06c522c2c52e01ffe5b02f1eeaf7d83</guid>
				<title>Jain posted an update: 68), followed by AVLT total learning (AUC 0.66) and AVLT [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32663/</link>
				<pubDate>Tue, 28 Jan 2025 19:24:35 -0800</pubDate>

									<content:encoded><![CDATA[<p>68), followed by AVLT total learning (AUC 0.66) and AVLT Recognition (AUC 0.59) scores, providing useful cut off values in the clinical setting.Conclusions Use of neuropsychological testing, specifically AVLT scores with cutoff values, contributed to the correct diagnosis of MCI due to AD in this SouthAmerican cohort.This article addresses the&hellip;<span class="activity-read-more" id="activity-read-more-32663"><a href="http://www.nationalboardinstitute.com/activity/p/32663/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">59d0d30c26aa5ba120b2e0bdab9a6801</guid>
				<title>Jain became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32652/</link>
				<pubDate>Tue, 28 Jan 2025 19:22:01 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>